Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01516307 |
Recruitment Status
:
Active, not recruiting
First Posted
: January 24, 2012
Last Update Posted
: March 3, 2017
|
Sponsor:
OBI Pharma, Inc
Information provided by (Responsible Party):
OBI Pharma, Inc
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Actual Primary Completion Date : | August 2016 |
Estimated Study Completion Date : | August 2019 |
Certification/Extension First Submitted : | March 2, 2017 |